443 related articles for article (PubMed ID: 28946567)
21. In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
Dronse J; Fliessbach K; Bischof GN; von Reutern B; Faber J; Hammes J; Kuhnert G; Neumaier B; Onur OA; Kukolja J; van Eimeren T; Jessen F; Fink GR; Klockgether T; Drzezga A
J Alzheimers Dis; 2017; 55(2):465-471. PubMed ID: 27802224
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of Down syndrome and Alzheimer's disease effects with imaging.
Matthews DC; Lukic AS; Andrews RD; Marendic B; Brewer J; Rissman RA; Mosconi L; Strother SC; Wernick MN; Mobley WC; Ness S; Schmidt ME; Rafii MS
Alzheimers Dement (N Y); 2016 Jun; 2(2):69-81. PubMed ID: 28642933
[TBL] [Abstract][Full Text] [Related]
23. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
24. What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
Andriuta D; Moullart V; Schraen S; Devendeville A; Meyer ME; Godefroy O;
J Alzheimers Dis; 2016; 51(3):793-800. PubMed ID: 26923012
[TBL] [Abstract][Full Text] [Related]
25. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
[TBL] [Abstract][Full Text] [Related]
26. Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
Hartley SL; Fleming V; Schworer EK; Peven J; Handen BL; Krinsky-McHale S; Hom C; Lee L; Tudorascu DL; Laymon C; Minhas D; Luo W; Cohen A; Zaman S; Ances BM; Mapstone M; Head E; Lai F; Rosas HD; Klunk W; Christian B;
J Alzheimers Dis; 2023; 95(1):213-225. PubMed ID: 37482997
[TBL] [Abstract][Full Text] [Related]
27. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
Lemoine L; Ledreux A; Mufson EJ; Perez SE; Simic G; Doran E; Lott I; Carroll S; Bharani K; Thomas S; Gilmore A; Hamlett ED; Nordberg A; Granholm AC
Mol Neurodegener; 2020 Nov; 15(1):68. PubMed ID: 33222700
[TBL] [Abstract][Full Text] [Related]
28. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.
Aschenbrenner AJ; Gordon BA; Benzinger TLS; Morris JC; Hassenstab JJ
Neurology; 2018 Aug; 91(9):e859-e866. PubMed ID: 30068637
[TBL] [Abstract][Full Text] [Related]
29. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers.
Janelidze S; Christian BT; Price J; Laymon C; Schupf N; Klunk WE; Lott I; Silverman W; Rosas HD; Zaman S; Mapstone M; Lai F; Ances BM; Handen BL; Hansson O
JAMA Neurol; 2022 Aug; 79(8):797-807. PubMed ID: 35789365
[TBL] [Abstract][Full Text] [Related]
30. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
31. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Sabbagh MN; Chen K; Rogers J; Fleisher AS; Liebsack C; Bandy D; Belden C; Protas H; Thiyyagura P; Liu X; Roontiva A; Luo J; Jacobson S; Malek-Ahmadi M; Powell J; Reiman EM
Alzheimers Dement; 2015 Aug; 11(8):994-1004. PubMed ID: 25849033
[TBL] [Abstract][Full Text] [Related]
32. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
[TBL] [Abstract][Full Text] [Related]
33. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
[TBL] [Abstract][Full Text] [Related]
34. Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome.
Grigorova M; Mak E; Brown SSG; Beresford-Webb J; Hong YT; Fryer TD; Coles JP; Aigbirhio FI; Tudorascu D; Cohen A; Christian BT; Ances B; Handen BL; Laymon CM; Klunk WE; Clare ICH; Holland AJ; Zaman SH
Neurobiol Aging; 2022 Nov; 119():36-45. PubMed ID: 35964542
[TBL] [Abstract][Full Text] [Related]
35. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
36. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
37. Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type.
Lagarde J; Olivieri P; Tonietto M; Gervais P; Comtat C; Caillé F; Bottlaender M; Sarazin M
Transl Psychiatry; 2021 Sep; 11(1):498. PubMed ID: 34588422
[TBL] [Abstract][Full Text] [Related]
38. Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneity.
Mohanty R; Ferreira D; Nordberg A; Westman E;
Alzheimers Res Ther; 2023 Feb; 15(1):37. PubMed ID: 36814346
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
[TBL] [Abstract][Full Text] [Related]
40. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.
Grothe MJ; Teipel SJ;
Hum Brain Mapp; 2016 Jan; 37(1):35-53. PubMed ID: 26441321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
